| Logo | Name | Σ |
|---|---|---|
 | Digital Aquitaine Together develop the digital economy Digital Aquitaine is the association that works for the economic development of businesses and other players in the digital sector in Aquitaine (training, research ...). Digital Aquaine works like a competitiveness center and acts as a unifying skills and initiative hub in Aquitaine. Its main missions are practiced on: - The emergence of large -scale collaborative projects with the aim of visibility, animation and promotion of the sector at the regional, national and international level. -The creation of wealth and employment in the region. Digital Aquitaine is an association created on November 3, 2014, by … | 640 |
 | Groupe Hospitalier Diaconesses Croix Saint-Simon In the health service The Diaconesses Hospital Group Cross Saint-Simon is a hospital offering excellence in medicine, surgery and obstetrics without depending on the patient. Located east of Paris (close to the Place de la Nation), it supports 250,000 patients each year for preventive, diagnostic, curative and palliative acts. The establishment offers a large offer of care: internal medicine, orthopedic, digestive, gynecological and urological surgeries, proctology, oncology, rheumatology, acute geriatrics, emergencies, maternity and palliative care. It is also one of the most efficient fertility centers to date. Historically a pioneer in many areas and always turned to the future, the … Sectors: | 73 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1652 |
 | AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: | 3896 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: | 272 |
Health